Home/LDN Therapy/Blog/What Is Low Dose Naltrexone? A Beginner's Guide
BasicsSeptember 1, 2026·6 min read

What Is Low Dose Naltrexone? A Beginner's Guide

G
Gregg MacDonald, APRN
Pineapple Primary Care

Low Dose Naltrexone — or LDN — is one of the most talked-about treatments in integrative medicine right now. But for most people, the name alone raises questions. Is it related to opioids? Is it a new drug? Is it safe?

Let's clear all of that up.

What Is Naltrexone?

Naltrexone is an FDA-approved medication that has been around since the 1980s. At its standard dose (50mg), it's used to treat opioid and alcohol addiction by blocking opioid receptors in the brain. It's well-studied, well-tolerated, and widely available.

So What Is "Low Dose" Naltrexone?

LDN refers to naltrexone taken at a fraction of the standard dose — typically between 1.5mg and 4.5mg, or roughly 1/10th of the dose used for addiction. At this dramatically reduced dose, naltrexone works through completely different mechanisms than it does at full dose.

Rather than simply blocking opioid receptors all day, LDN creates a brief, temporary blockade — usually taken at bedtime — that triggers a rebound effect. The body responds by upregulating its own endorphin production and, crucially, modulating the immune system.

How Does It Work at Low Doses?

LDN's primary mechanisms at low doses are:

1. Endorphin boost. The brief receptor blockade signals the body to produce more endogenous opioids (your body's natural pain-relieving, mood-regulating compounds). This upregulation persists beyond the short blockade window.

2. Microglial modulation. LDN appears to calm overactivated microglial cells — the immune cells of the central nervous system. When microglia become hyperactivated (as they do in many chronic conditions), they drive neuroinflammation, pain, and fatigue. LDN quiets this response.

3. Immune regulation. Rather than broadly suppressing the immune system (as many conventional treatments do), LDN appears to normalize immune function — calming an overactive immune system while supporting appropriate immune responses.

Why Is It Off-Label?

LDN is prescribed off-label because no pharmaceutical company has funded the expensive clinical trials needed for FDA approval at low doses. Naltrexone is a cheap, generic medication — there's no profit incentive for a drug company to go through the approval process. This doesn't mean LDN is experimental or unsafe. It means the evidence has been built by researchers, universities, and patient advocates rather than a pharmaceutical sponsor.

Is It Safe?

LDN has an exceptional safety record. It has been used clinically for over 30 years. The most commonly reported side effect is vivid dreams or mild sleep disruption when first starting — which typically resolves within the first few weeks. Serious side effects are rare.

The main contraindication is concurrent use of opioid medications — LDN and opioids cannot be taken together, as they work through opposing mechanisms.

Who Might Benefit?

LDN has been studied in over 50 conditions, including:

  • Autoimmune diseases (MS, Crohn's, Hashimoto's, lupus, rheumatoid arthritis)
  • Chronic pain conditions (fibromyalgia, CRPS)
  • Neurological conditions (Parkinson's, ALS)
  • Long COVID and ME/CFS
  • Cancer (as an adjunct to conventional treatment)
  • Mental health (depression, anxiety)

What's the Bottom Line?

LDN is a low-cost (~$30–60/month from a compounding pharmacy), simple, well-tolerated treatment with a growing evidence base and decades of clinical use. It's not a miracle cure, but for many patients with conditions where conventional medicine has fallen short, it offers real hope.

If you're curious whether LDN might be right for you, the best next step is a conversation with a knowledgeable provider. At Pineapple Primary Care, we offer LDN consultations via telehealth throughout Florida.

Questions About LDN?

Book a free telehealth consultation with Pineapple Primary Care to discuss whether LDN is right for your situation. Available throughout Florida.

Book a Free LDN Consultation

Low Dose Naltrexone (LDN) is not FDA-approved for any indication. While naltrexone is an FDA-approved medication at standard doses for opioid and alcohol dependence, the use of naltrexone at low doses is considered off-label prescribing. This website provides educational information about LDN based on published clinical literature and patient experiences. Any discussion or consideration of LDN therapy should occur only in consultation with a qualified healthcare provider who can evaluate your individual medical history, current medications, and clinical circumstances. Pineapple Primary Care does not guarantee any specific outcome from LDN therapy and assumes no liability for decisions made based on this information. Always consult with your healthcare provider before starting, stopping, or modifying any medication.